Mohamed Snoussi

Define the company's industrial and development strategy. Implement the organization in accordance with pharmaceutical industry standards. Define bills of materials and operating procedures. Implement production KPIs. Implement quality KPIs. Implement a continuous improvement strategy. Ensure the success of Group quality audits. Ensure the success of regulatory inspections. Set up a new physico-chemical control laboratory. Company market share growth; 18% (2016) / 40% (2020)

Director of Industrial Operations, Pharmaceutical Development, and Responsible Pharmacist (Qualified Person). Contribution to the company's industrial and development strategy (rolling 5-year business plans). Optimization of industrial tools and human resources. Organization of industrial working committees. Subcontracting management (partner identification, contribution to partnership agreements and industrial transfer). Annual performance reviews with objective setting. Generic product development. Industrial management reporting to the Group. Member of the management committee. Participation in Board of Directors meetings. Set up a remote finished product warehouse (Pilot project, a first in Tunisia). Quality audit conducted on December 7-8, 2011, on behalf of the Pierre Fabre Group in Algiers at Laboratoire Somedial.